已发表论文

老年女性系统性免疫炎症指数和CA125之间的关联:来自NHANES横断面研究的见解

 

Authors Gao L, Xu F, Zhen S, Cai Y

Received 5 September 2024

Accepted for publication 17 November 2024

Published 27 November 2024 Volume 2024:16 Pages 1981—1991

DOI https://doi.org/10.2147/IJWH.S492712

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Vinay Kumar

Ling Gao, Fengyun Xu, Suli Zhen, Yaping Cai

Department of Gynecology and Obstetrics, Jinjiang Hospital Traditional Chinese Medicine, Jinjiang, Fujian, 362200, People’s Republic of China

Correspondence: Yaping Cai, Department of Gynecology and Obstetrics, Jinjiang Hospital Traditional Chinese Medicine, No. 1105 Quan’an Middle Road, Jinjiang, Fujian, 362200, People’s Republic of China, Email fjmu2022@163.com

Introduction: The Systemic Immune-Inflammation Index (SII) is a novel biomarker that has been implicated in the pathogenesis of various neoplastic and non-neoplastic diseases. This study aimed to evaluate the association between SII and the conventional tumor marker CA125 (Carbohydrate antigen 125) in a population of postmenopausal women.
Methods: This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES), focusing on postmenopausal women with available data on SII and CA125. The SII was calculated using the formula: platelet count × neutrophil count/lymphocyte count. To evaluate the relationship between the SII and cancer antigen 125 (CA125), we conducted multivariate regression analyses. The linear association between these variables was further explored by fitting a smoothed curve to examine nuances in their relationship. Additionally, subgroup analyses were performed based on age, age at menarche and menopause, and hormone replacement therapy status to assess the heterogeneity of the relationship between SII and CA125 between different demographic groups.
Results: A total of 741 postmenopausal women with a mean age of 72.0 (± 8.24) years were included in this analysis. The results demonstrated a significant positive correlation between SII and CA125 levels (β = 0.01; 95% CI, 0.00– 0.02, p = 0.0128). Subgroup analyses and interaction tests revealed that variables such as age, age at menarche and menopause, and hormone replacement therapy did not significantly modify this association (p > 0.05).
Conclusion: This study demonstrated a positive correlation between SII and C125 in older female patients in the United States.

Keywords: elderly women, SII, CA125, NHANES, cross-sectional study